Chronic consumption of a wild green oat extract (Neuravena) improves brachial flow-mediated dilatation and cerebrovascular responsiveness in older adults

Journal of Hypertension

Volumn 31, Issue 1, 2013, Pages 192-200

  Wong, Rachel H X ^a   Howe, Peter R C ^a   Coates, Alison M ^a   Buckley, Jonathan D ^a   Berry, Narelle M ^a  

^a UNIVERSITY OF SOUTH AUSTRALIA   (Australia)

Author keywords

Avena sativa; avenanthramides; bioactive nutrients; cerebrovascular responsiveness; flow mediated dilatation; wild green oats

Indexed keywords

PLACEBO; PLANT EXTRACT; UNCLASSIFIED DRUG; WILD GREEN OAT EXTRACT;

ADULT; AGED; ARTICLE; BLOOD FLOW; BLOOD VESSEL REACTIVITY; BRACHIAL ARTERY; CEREBRAL VASODILATOR RESPONSIVENESS; CLINICAL ARTICLE; CONTROLLED STUDY; CROSSOVER PROCEDURE; DIETARY INTAKE; DOUBLE BLIND PROCEDURE; FEMALE; HUMAN; HYPERCAPNIA; MALE; MIDDLE CEREBRAL ARTERY; OAT; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TREATMENT DURATION; VASODILATATION; WILD GREEN OAT;

EID: 84995289724     PISSN: 02636352     EISSN: 14735598     Source Type: Journal    
DOI: 10.1097/HJH.0b013e32835b04d4     Document Type: Article

References (47)

1. Celermajer DS, Sorensen KE, Bull C, Robinson J, Deanfield JE. Endothelium-dependent dilation in the systemic arteries of asymptomatic subjects related to coronary risk-factors and their interaction. J Am Coll Cardiol 1994; 24:1468-1474.
2. Anderson TJ, Uehata A, Gerhard MD, Meredith IT, Knab S, Delagrange D, et al. Close relation of endothelial function in the human coronary and peripheral circulations. J Am Coll Cardiol 1995; 26:1235-1241.
3. Yavuz BB, Yavuz B, Sener DD, Cankurtaran M, Halil M, Ulger Z, et al. Advanced age is associated with endothelial dysfunction in healthy elderly subjects. Gerontology 2008; 54:153-156.
4. Yeboah J, Crouse JR, Hsu F-C, Burke GL, Herrington DM. Brachial flowmediated dilation predicts incident cardiovascular events in older adults. Circulation 2007; 115:2390-2397.
5. Santos-Garcia D, Blanco M, Serena J, Rodriguez-Yanez M, Leira R, Castillo J. Impaired brachial flow-mediated dilation is a predictor of a new-onset vascular event after stroke. Cerebrovasc Dis 2011; 32:155-162.
6. Stevenson SF, Doubal FN, Shuler K, Wardlaw JM. A systematic review of dynamic cerebral and peripheral endothelial function in lacunar stroke versus controls. Stroke 2010; 41:e434-e442.
7. Pretnar-Oblak J, Sabovic M, Zaletel M. Associations between systemic and cerebral endothelial impairment determined by cerebrovascular reactivity to L-arginine. Endothelium 2007; 14:73-80.
8. Perko D, Pretnar-Oblak J, Sabovic M, Zaletel M, Zvan B. Associations between cerebral and systemic endothelial function in migraine patients: a posthoc study. BMC Neurol 2011; 11:146.
9. Suessenbacher A, Frick M, Alber HF, Barbieri V, Pachinger O, Weidinger F. Association of improvement of brachial artery flowmediated vasodilation with cardiovascular events. Vasc Med 2006; 11:239-244.
10. Liu S, Stampfer MJ, Hu FB, Giovannucci E, Rimm E, Manson JE, et al. Whole-grain consumption and risk of coronary heart disease: results from the Nurses' Health Study. Am J Clin Nutr 1999; 70:412-419.
11. Jacobs DR, Meyer KA, Kushi LH, Folsom AR. Whole-grain intake may reduce the risk of ischemic heart disease death in postmenopausal women: the Iowa Women's Health Study. Am J Clin Nutr 1998; 68:248-257.
12. Ruxton CHS, Derbyshire E. A systematic review of the association between cardiovascular risk factors and regular consumption of oats. Br Food J 2008; 110:1119-1132.
13. Kelly SA, Summerbell CD, Brynes A, Whittaker V, Frost G. Wholegrain cereals for coronary heart disease. Cochrane Database Syst Rev 2007:CD005051. http://www.mrw.interscience.wiley.com/cochrane/clsysrev/articles/CD005051/frame. html.
14. Keenan JM, Pins JJ, Frazel C, Moran A, Turnquist L. Oat ingestion reduces systolic and diastolic blood pressure in patients with mild or borderline hypertension: a pilot trial. J Fam Pract 2002; 51:369.
15. Katz DL, Evans MA, Chan W, Nawaz H, Comerford BP, Hoxley ML, et al. Oats, antioxidants and endothelial function in overweight, dyslipidemic adults. J Am Coll Nutr 2004; 23:397-403.
16. Abascal K, Yarnell E. Nervine herbs for treating anxiety. Altern Complement Therap 2004; 10:309-315.
17. Jacobs D, Gallaher D. Whole grain intake and cardiovascular disease: a review. Curr Atheroscler Rep 2004; 6:415-423.
18. Ryan D, Kendall M, Robards K. Bioactivity of oats as it relates to cardiovascular disease. Nutr Res Rev 2007; 20:147-162.
19. Guo W, Wise ML, Collins FW, Meydani M. Avenanthramides, polyphenols from oats, inhibit IL-1b-induced NF-kB activation in endothelial cells. Free Radical Biol Med 2008; 44:415-429.
20. Sur R, Nigam A, Grote D, Liebel F, Southall M. Avenanthramides, polyphenols from oats, exhibit anti-inflammatory and antiitch activity. Arch Dermatol Res 2008; 300:569-574.
21. Nie L, Wise ML, Peterson DM, Meydani M. Avenanthramide, a polyphenol from oats, inhibits vascular smooth muscle cell proliferation and enhances nitric oxide production. Atherosclerosis 2006; 186:260-266.
22. Mattila P, Pihlava JM, Hellstrom J. Contents of phenolic acids, alkyland alkenylresorcinols, and avenanthramides in commercial grain products. J Agric Food Chem 2005; 53:8290-8295.
23. Peterson DM, Dimberg LH. Avenanthramide concentrations and hydroxycinnamoyl-CoA:hydroxyanthranilate N-hydroxycinnamoyltransferase activities in developing oats. J Cereal Sci 2008; 47:101-108.
24. Chen C-YO, Milbury PE, Collins FW, Blumberg JB. Avenanthramides are bioavailable and have antioxidant activity in humans after acute consumption of an enriched mixture from oats. J Nutr 2007; 137:1375-1382.
25. Peterson DM, Hahn MJ, Emmons CL. Oat avenanthramides exhibit antioxidant activities in vitro. Food Chem 2002; 79:473-478.
26. Moccetti TWC, Schmidt A, Aydogan C, Kreuter MH. Bioactivity-based development of a wild green oat (Avena sativa L.) extract in support of mental health disorders. Z Phytother 2006; 27:24.
27. Berry NM, Robinson MJ, Bryan J, Buckley JD, Murphy JK, Howe PRC. Acute effects of an Avena sativa-herba extract on responses to the Stroop colour-word test. J Altern Complement Med 2011; 17:635-637.
28. Sinn N, Howe PRC. Mental health benefits of omega-3 fatty acids may be mediated by improvements in cerebral vascular function. Biosci Hypoth 2008; 1:103-108. doi: 10.1016/j.bihy.2008.02.003.
29. Peng X, Zheng Z, Cheng K-W, Shan F, Ren G-X, Chen F, Wang M. Inhibitory effect of mung bean extract and its constituents vitexin and isovitexin on the formation of advanced glycation endproducts. Food Chem 2008; 106:475-481.
30. Lacaille-Dubois MA, Wagner H. A review of the biological and pharmacological activities of saponins. Phytomedicine 1996; 2:363-386.
31. Davison K, Coates AM, Buckley JD, Howe PR. Effect of cocoa flavanols and exercise on cardiometabolic risk factors in overweight and obese subjects. Int J Obes (Lond) 2008; 32:1289-1296.
32. Kalbe E, Kessler J, Calabrese P, Smith R, Passmore AP, Brand M, Bullock R. DemTect: a new, sensitive cognitive screening test to support the diagnosis of mild cognitive impairment and early dementia. Int J Geriatr Psychiatry 2004; 19:136-143.
33. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL Jr, et al. Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension 2003; 42:1206-1252.
34. Nicoletto HA, Burkman MH. Transcranial Doppler series part II: performing a transcranial Doppler. Am J Electroneurodiagnostic Technol 2009; 49:14-27.
35. Harris RA, Nishiyama SK, Wray DW, Richardson RS. Ultrasound assessment of flow-mediated dilation. Hypertension 2010; 55:1075-1085.
36. Hooper L, Kroon PA, Rimm EB, Cohn JS, Harvey I, Le Cornu KA, et al. Flavonoids, flavonoid-rich foods, and cardiovascular risk: a meta-analysis of randomized controlled trials. Am J Clin Nutr 2008; 88:38-50.
37. Wang Q, Liang X, Wang L, Lu X, Huang J, Cao J, et al. Effect of omega-3 fatty acids supplementation on endothelial function: a meta-analysis of randomized controlled trials. Atherosclerosis 2012; 221:536-543.
38. Caramori PR, Zago AJ. Endothelial dysfunction and coronary artery disease. Arq Bras Cardiol 2000; 75:163-182.
39. Perticone F, Ceravolo R, Pujia A, Ventura G, Iacopino S, Scozzafava A, et al. Prognostic significance of endothelial dysfunction in hypertensive patients. Circulation 2001; 104:191-196.
40. Naseem KM. The role of nitric oxide in cardiovascular diseases. Mol Aspects Med 2005; 26:33-65.
41. Yeboah J, Sutton-Tyrrell K, McBurnie MA, Burke GL, Herrington DM, Crouse JR. Association between brachial artery reactivity and cardiovascular disease status in an elderly cohort: the cardiovascular health study. Atherosclerosis 2008; 197:768-776.
42. Davison K, Bircher S, Hill A, Coates AM, Howe PR, Buckley JD. Relationships between obesity, cardiorespiratory fitness, and cardiovascular function. J Obes 2010; 2010:191253.
43. Zimmermann C, Haberl RL. L-arginine improves diminished cerebral CO2 reactivity in patients. Stroke 2003; 34:643-647.
44. Markus H, Cullinane M. Severely impaired cerebrovascular reactivity predicts stroke and TIA risk in patients with carotid artery stenosis and occlusion. Brain 2001; 124:457-467.
45. King A, Serena J, Bornstein NM, Markus HS. Does impaired cerebrovascular reactivity predict stroke risk in asymptomatic carotid stenosis? A prospective substudy of the asymptomatic carotid emboli study. Stroke 2011; 42:1550-1555.
46. Moncada S, Palmer RM, Higgs EA. Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol Rev 1991; 43:109-142.
47. Toda N. Age-related changes in endothelial function and blood flow regulation. Pharmacol Ther 2012; 133:159-176.